These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 8691449)
1. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448 [TBL] [Abstract][Full Text] [Related]
3. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity. Lee HH; Wilson WR; Denny WA Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells. Palmer BD; Wilson WR; Cliffe S; Denny WA J Med Chem; 1992 Aug; 35(17):3214-22. PubMed ID: 1507207 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. Palmer BD; Wilson WR; Atwell GJ; Schultz D; Xu XZ; Denny WA J Med Chem; 1994 Jul; 37(14):2175-84. PubMed ID: 8035424 [TBL] [Abstract][Full Text] [Related]
6. Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs. Palmer BD; Wilson WR; Denny WA Anticancer Drug Des; 1990 Nov; 5(4):337-49. PubMed ID: 2291774 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine. Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. Tercel M; Wilson WR; Anderson RF; Denny WA J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and hypoxia-selective cytotoxicity of a 2-nitroimidazole mustard. Lee HH; Palmer BD; Wilson WR; Denny WA Bioorg Med Chem Lett; 1998 Jul; 8(13):1741-4. PubMed ID: 9873426 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs. Siim BG; Atwell GJ; Anderson RF; Wardman P; Pullen SM; Wilson WR; Denny WA J Med Chem; 1997 Apr; 40(9):1381-90. PubMed ID: 9135035 [TBL] [Abstract][Full Text] [Related]
11. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug. Moselen JW; Hay MP; Denny WA; Wilson WR Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627 [TBL] [Abstract][Full Text] [Related]
12. Nitroimidazole-based "extruded mustards' designed as reductively activated hypoxia-selective cytotoxins. Hay MP; Denny WA; Wilson WR Anticancer Drug Des; 1996 Jul; 11(5):383-402. PubMed ID: 8765531 [TBL] [Abstract][Full Text] [Related]
13. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine. Hay MP; Pruijn FB; Gamage SA; Liyanage HD; Kovacs MS; Patterson AV; Wilson WR; Brown JM; Denny WA J Med Chem; 2004 Jan; 47(2):475-88. PubMed ID: 14711317 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines. Shyam K; Penketh PG; Shapiro M; Belcourt MF; Loomis RH; Rockwell S; Sartorelli AC J Med Chem; 1999 Mar; 42(5):941-6. PubMed ID: 10072691 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers. Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864 [TBL] [Abstract][Full Text] [Related]
16. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase. Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209 [TBL] [Abstract][Full Text] [Related]
17. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines. Palmer BD; Wilson WR; Pullen SM; Denny WA J Med Chem; 1990 Jan; 33(1):112-21. PubMed ID: 2296009 [TBL] [Abstract][Full Text] [Related]
19. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline]. Skov KA; Adomat H; Doedee M; Farrell N Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927 [TBL] [Abstract][Full Text] [Related]
20. NLNQ-1, a 2-[3-(2-nitro-1-imidazolyl) propylamino]-3-chloro-1,4-naphthoquinone, as a hypoxia-selective cytotoxin and radiosensitizer. Papadopoulou MV; Bloomer WD In Vivo; 2008; 22(3):285-8. PubMed ID: 18610737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]